Apogee Therapeutics, Inc. (APGE) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Medium Risk

Moderate dilution risk

Last updated: May 11, 2026

Risk Assessment Details

Potential Dilution: 11.15% of current shares

Recent Dilution: 50.63% (2 years)

Historical Dilution Factor: significant recent dilution

Outstanding Shares

62M

Potential Supply

6.9M

Additional shares possible

Splits

None

Past 2 years

Summary

APGE currently has 61.9M outstanding shares. with limited dilution risk as only 6.9M additional shares (11.1%) are authorized for issuance. The company has significantly diluted shareholders by 50.63% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
May 11, 2026	10-Q filing \| 61.9M shares outstanding	62M	6.9M
Nov 10, 2025	10-Q filing \| 68.3M shares outstanding	68M	6.9M
Oct 10, 2025	8-K filing: Apogee Therapeutics, Inc. entered into an underwriting agreement to issue and sell 6,951,221 shares of common stock at $41.00 per share and pre-funded warrants to purchase 365,853 shares at $40.99999 per share. Underwriters exercised an option to purchase an additional 1,097,561 shares at the public offering price. ($323.3M proceeds)	46M	6.9M
Aug 11, 2025	10-Q filing \| 46.1M shares outstanding	46M	6.9M
May 12, 2025	10-Q filing \| 46.0M shares outstanding	46M	6.9M
Mar 03, 2025	10-K filing \| 46.0M shares outstanding	46M	6.9M
Nov 12, 2024	10-Q filing \| 45.0M shares outstanding	45M	6.9M
Aug 12, 2024	10-Q filing \| 45.0M shares outstanding	45M	6.9M
May 13, 2024	10-Q filing \| 45.0M shares outstanding	45M	6.9M
Mar 05, 2024	10-K filing \| 37.2M shares outstanding	37M	6.9M
Mar 05, 2024	S-1 filing: Apogee Therapeutics, Inc. is offering 6,000,000 shares of common stock in an S-1 filing.	37M	6.9M
Nov 13, 2023	10-Q filing \| 37.2M shares outstanding	37M	0
Aug 28, 2023	10-Q filing \| 37.2M shares outstanding	37M	0
Jul 10, 2023	S-1/A filing: This is an S-1/A filing for common stock, acting as a preliminary prospectus.	N/A	0
Jun 22, 2023	S-1 filing: This is an S-1 filing for an initial public offering of common stock underwritten by Guggenheim Securities and Wedbush Pacgrow.	N/A	0

Back to APGE Details